Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Laekna Therapeutics
company
About
Laekna Therapeutics is a biotech company focusing on drug discovery and development.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $18.50M
- Industries
- Biotechnology
- Founded date
- Dec 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development. Targeting large unmet medical needs, Laekna is dedicated to developing new therapies for cancer and liver diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$79.50M
Laekna Therapeutics has raised a total of
$79.50M
in funding over 2 rounds. Their latest funding was raised on
May 18, 2022 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 18, 2022 | Series D | $61M | 1 | — | — | Detail |
| Jun 4, 2018 | Series A | $18.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Laekna Therapeutics is funded by 2 investors.
Infinity Capital
and Anlongmed Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Infinity Capital
|
— | Series D |
Anlongmed Fund
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
